arrow
F

Filippo Luca Gurgoglione

Cardiology Department
H指数:13
被引数:971

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Atrial fibrillation and coexisting cerebral amyloid angiopathy: safety and efficacy of transcatheter left atrial appendage occlusion

心房颤动与并存脑血管淀粉样变性:经导管左心耳封堵的安全性与有效性

2026-04-230
PRE
The Impact of Sodium Glucose Co-Transporter 2 (SGLT-2) Inhibitors on Atherogenesis: A Systematic Review of Experimental and Clinical Evidence

钠-葡萄糖协同转运蛋白2(SGLT-2)抑制剂对动脉粥样硬化形成的影响:实验和临床证据的系统评价

Life
IF3.4
2026-03-030
OAAI
The Vagal Link: Autonomic Nervous System Dysfunction in Cardiac Amyloidosis

迷走神经关联:心脏淀粉样变性中的自主神经系统功能障碍

2025-12-190
OAAI
Prognostic Role and Therapeutic Implications of Intravascular Optical Coherence Tomography Detected Coronary Plaque Microstructures in Patients with Coronary Artery Disease

血管内光学相干断层扫描检测的冠状动脉斑块微结构的预后作用和治疗意义在冠状动脉疾病患者中的应用

2025-11-180
OAAI
Risk Stratification and Optimal Use of Implantable Cardioverter-Defibrillator Therapy in Primary Prevention of Sudden Cardiac Death in Genetic Cardiomyopathies, with Assessment of the Role of Genetic Variants in Guiding Therapeutic Decisions

遗传性心肌病中,心源性猝死一级预防的植入式心律转复除颤器疗法的风险分层与最佳应用,并评估遗传变异在指导治疗决策中的作用

2025-10-270
OAAI
Arrhythmogenic Cardiomyopathy and Biomarkers: A Promising Perspective?

致心律失常性心肌病与生物标志物:一个有前景的视角?

2025-10-050
OAAI
Sex-Related Differences in the Prognostic Role of Acetylcholine Provocation Testing
2025-02-251
OAAI
Cardiovascular Disease from Pathophysiology to Risk Estimation: Is Inflammation Estimated through Perivascular Attenuation on Computed Tomography the Key?
2024-03-290
OAAI